Barely Significant
← all excerpts

NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Hepatol Commun · 2018 · PMC6128239 · PMID 30202819

Europe PMCDOI
2
hedged sentences
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendP = 0.07so close (0.05 < p ≤ 0.1)
LDL‐C levels in the NGM282 3‐mg group showed a trend toward improvement (−13.1 mg/dL), albeit not significant ( P = 0.07).

also in 53,322 other papers

did not reach statistical significanceno p-value reported
There was a dose‐dependent decrease in serum concentrations of total bile acids, but this did not reach statistical significance (Fig. 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.